2010•Medical Journal of Chinese People's HealthRequires access

Comparison of efficacy and safety of Escitalopram and Mirtazapine in the treatment of depression

Yantao Wang

Abstract

Objective:To compare the efficacy and safety of Escitalopram and Mirtazapine in the treatment of depression.Methods:68 patients with depression by CCMD-3 were randomly allocated to two groups with Escitalopram or Mirtazapine for 8 weeks.HAMD CGI-SI scale and TESS scale were used to evaluate efficacy and side effects respectively before and at the ends of 1,2,4,6,8 weeks of treatment.Results: The total effective rates for the Escitalopram and Mirtazapine groups were similar after 8 weeks(P0.05).Incidence of side effects in the Escitalopram group was lower than that in the Mirtazapine group.Conclusions: The results suggest that Escitalopram is effective and safe anti-depression drug.

About this research paper

What this paper is about

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Key concepts: Escitalopram, Mirtazapine, Hamd, Depression (economics), Medicine, Psychiatry, Significant difference, Psychology